AltheaDx, Inc.
$65M
AltheaDx is a California-based commercial-stage molecular diagnostics company that offers pharmacogenomics testing services for patients and clinicians.
Cernostics, Inc.
$50M
Cernostics is a provider of tissue-based cancer diagnostics and prognostics test solutions.
-
Myriad myPath Laboratory, Myriad Genetics
$32.5M
-